Cargando…

Does Losartan reduce the severity of COVID-19 in hypertensive patients?

BACKGROUND: One of the global problems is to control the coronavirus epidemic, and the role of different medicines is still unknown to policymakers. This study was conducted to evaluate the effects of losartan on the mortality rate of COVID-19 in hypertensive patients. METHODS: The research sample o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirjalili, Mohammadreza, Soodejani, Moslem Taheri, Raadabadi, Mehdi, Dehghani, Ali, Salemi, Fateme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933856/ https://www.ncbi.nlm.nih.gov/pubmed/35305551 http://dx.doi.org/10.1186/s12872-022-02548-2

Ejemplares similares

The impact of COVID-19 Vaccination in Iranian elderly: 7 percent of all-cause deaths reduced by vaccinating 2 percent of population; letter to editor
por: Jambarsang, Sara, et al.
Publicado: (2022)

Five Common Cancers in Iran in 2019: Secondary Analysis to Discovering Cluster of Cancers
por: Taheri Soodejani, Moslem
Publicado: (2023)

Is case fatality rate an appropriate index to represent the status of case-finding process for COVID-19 in different countries?
por: Taheri Soodejani, Moslem, et al.
Publicado: (2020)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

COVID-19 vaccine in pregnant women and pregnancy outcomes: A historical cohort in center of Iran
por: Zare Sakhvidi, Mahdi, et al.
Publicado: (2023)

Traffic accident mortality in Najafabad, Iran: a time series model
por: Taheri Soodejani, Moslem, et al.
Publicado: (2019)

The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017
por: Taheri Soodejani, Moslem, et al.
Publicado: (2019)

The increasing trend of blood donation in Iran
por: Taheri Soodejani, Moslem, et al.
Publicado: (2019)

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
por: Kjeldsen, S E, et al.
Publicado: (2010)

The Association between Adverse Events in the Last 5 Years and the Rate of Breast Cancer
por: RASTEGARIMEHR, Babak, et al.
Publicado: (2018)

The trend of marriage, childbearing, and divorce and its determinants of socio-economic factors on divorce in Yazd province 2016-2021: A cross-sectional study
por: Tavakolian, Nastaran, et al.
Publicado: (2023)

Trend of Congenital Hypothyroidism Incidence and Its Affecting Factors in Shahr-e-Kord, Western Iran
por: TAHERI SOODEJANI, Moslem, et al.
Publicado: (2020)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Application of tuf gene sequence analysis for the identification of species of coagulase-negative staphylococci in clinical samples and evaluation of their antimicrobial resistance pattern
por: Khosravi, Azar Dokht, et al.
Publicado: (2018)

Bacteriospermia and its association with seminal fluid parameters and infertility in infertile men, Kerman, Iran: A cross-sectional study
por: Heidari Pebdeni, Parastou, et al.
Publicado: (2022)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
por: Park, C. G., et al.
Publicado: (2001)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Bharati, Sandesh Madhukar, et al.
Publicado: (2016)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
por: Wu, Liting, et al.
Publicado: (2021)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Analysis of Hospital Costs in Road Traffic Injuries
por: Emamgholipour, Sara, et al.
Publicado: (2021)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
por: Granström, Ola, et al.
Publicado: (2012)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
por: Mulinari-Santos, Gabriel, et al.
Publicado: (2019)

Losartan does not inhibit cigarette smoke-induced lung inflammation in mice
por: Hepworth, M. L., et al.
Publicado: (2019)

Population Size Estimation of Tramadol Misusers in Urban Population in Iran: Synthesis of Methods and Results
por: Nasiri, Naser, et al.
Publicado: (2019)

Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19
por: Queiroz, Kamila A., et al.
Publicado: (2023)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Fifty years of struggle to control cutaneous leishmaniasis in the highest endemic county in Iran: A longitudinal observation inferred with interrupted time series model
por: Aflatoonian, Mohammadreza, et al.
Publicado: (2022)

Changes of Gene Expressions in Spontaneously Hypertensive Rat Model After Losartan Treatment
por: Cha, Ji Hei, et al.
Publicado: (2012)

Losartan Improved Antioxidant Defense, Renal Function and Structure of Postischemic Hypertensive Kidney
por: Ivanov, Milan, et al.
Publicado: (2014)

Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70
por: Costantino, Valeria Victoria, et al.
Publicado: (2021)

A Comparative Study of the Management of Stage 2 hypertension by Combined therapy with Losartan, Amlodipine and Hydrochlorothiazide
por: Jafarzadeh Esfehani, Reza, et al.
Publicado: (2012)

Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
por: Kim, Michael D., et al.
Publicado: (2021)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
por: Kim, Hyeon A, et al.
Publicado: (2023)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0cvgu8q21r4e3hq6u89dmekejd